Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Prima BioMed Ltd (NASDAQ:PBMD)

1.62
Delayed Data
As of 3:58pm ET
 0.00 / 0.00%
Today’s Change
1.40
Today|||52-Week Range
3.26
-30.77%
Year-to-Date
No recent news for Prima BioMed Ltd.

Today’s Trading

Previous close1.62
Today’s open1.63
Day’s range1.60 - 1.64
Volume30,603
Average volume (3 months)94,602
Market cap$38.2M
Dividend yield--
Data as of 3:58pm ET, 09/20/2017

Growth & Valuation

Earnings growth (last year)+0.21%
Earnings growth (this year)-1,139.69%
Earnings growth (next 5 years)+0.00%
Revenue growth (last year)-24.32%
P/E ratioNM
Price/Sales567.62
Price/Book1.27

Competitors

 Today’s
change
Today’s
% change
AEZSAEterna Zentaris Inc+0.05+2.38%
PRTOProteon Therapeutics...-0.10-6.25%
HTGMHTG Molecular Diagno...+0.11+5.98%
FSIFlexible Solutions I...-0.00-0.01%
Data as of 4:00pm ET, 09/20/2017

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$127.4K
Annual profit (last year)-$45.1M
Net profit margin-35,426.72%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
Marc Voigt
COO, Secretary &
General Counsel
Deanne Miller
Corporate headquarters
Sydney, New South Wales (nsw)

Forecasts